What's New at DiaPharma?
Posted: August 15, 2022
It’s Not Just Support. It’s Solutions. Meet Genesis Cautivar West Territory Manager Genesis Cautivar joined DiaPharma in July 2022. He is a native of Vancouver, British Columbia, Canada and currently resides in the Dallas-Fort Worth, Texas Metroplex. He received his B.S. in Medical Technology from Walla Walla University (WA). He has many years of experience in clinical labs, technica...Read More
Celebrate with us at THSNA and Learn about T-TAS® 01
Posted: August 15, 2022
It’s Not Just Support. It’s Solutions. STOP BY BOOTH 416 TO CELEBRATE WITH US AT THSNA 2022 DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business at the Thrombosis and Hemostasis Summit of North America (THSNA) this year in Chicago, IL. We would love to see old friends and meet new acquaintances August 16th – 18th at the Sheraton Grand Chicago in Booth...Read More
Celebrate with DiaPharma at THSNA 2022 and learn about Ceveron® s100
Posted: August 12, 2022
It’s Not Just Support. It’s Solutions. STOP BY BOOTH 416 TO CELEBRATE WITH US AT THSNA 2022 DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business at the Thrombosis and Hemostasis Summit of North America (THSNA) this year in Chicago, IL. We would love to see old friends and meet new acquaintances August 16th – 18th at the Sheraton Grand Chicago in Booth...Read More
Celebrate with DiaPharma at THSNA in Chicago
Posted: August 11, 2022
It’s Not Just Support. It’s Solutions. STOP BY BOOTH 416 TO CELEBRATE WITH US AT THSNA 2022 DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business at the Thrombosis and Hemostasis Summit of North America (THSNA) this year in Chicago, IL. We would love to see old friends and meet new acquaintances August 16th – 18th at the Sheraton Grand Chicago in Booth...Read More
Celebrate with DiaPharma at THSNA 2022
Event Date: August 16 - 18, 2022
Event Location: Sheraton Grand Chicago, 301 East North Water Street, Chicago, IL 60611, Booth #416
Diapharma is proud to celebrate 25 years in the hemostasis and coagulation business at the Thrombosis and Hemostasis Summit of North America (THSNA) this year in Chicago, IL. We would love to see old friends and meet new acquaintances August 16th – 18th at the Sheraton Grand Chicago in Booth #416. Our team will be eager to talk all things bleeding, clotting, and demo new technology in pl...Read More
Exploratory Biomarkers for Acute and Chronic Kidney Injury Studies
Posted: June 28, 2022
It’s Not Just Support. It’s Solutions. Spotlight on Acute and Chronic Kidney Injury Enhanced assays with improved sensitivity and specificity to assist in kidney disease studies L-FABP ● NGAL ● Osteopontin ● alpha-GST ● Cystatin C ● RBP4 ● Anti-EHEC There are large gaps in the information that standard kidney markers, like serum creatinine, can provide in the context of ...Read More
Clot Club #32
Posted: June 28, 2022
CHROMOGENIC FACTOR X ASSAYS vs the PT/INR TO MONITOR SUBJECTS ON COUMADIN THERAPY WHEN AN INDIVIDUAL APPROACH IS NECESSARY ...Read More
Visit DiaPharma at ISTH and Register to Win!
Posted: June 28, 2022
It’s Not Just Support. It’s Solutions. CONNECT WITH US AT ISTH 2022 Visit us at the ISTH 2022 Congress July 9-13 to learn about our full line of hemostasis clinical and research products. Stop by booth 1125 to discuss: Ceveron® s100 all-in-one coagulation analyzer Automated ADAMTS13, Thrombin Generation, FXIII Activity, C1-Inhibitor Activity, and more You name it, Ceveron® s100 c...Read More
Supporting International NASH Day
Posted: June 9, 2022
DiaPharma Supports International NASH Day Heppy the Liver Man with his Finishers Medal June 9, 2022 is International NASH Day (IND). IND is an initiative started by the Global Liver Institute to raise awareness of the growing worldwide epidemic of non-alcoholic fatty liver disease (NAFLD) and its more advanced form, non-alcoholic steatohepatitis (NASH). There are currently no approved drugs to ...Read More
International NASH Day (IND)
Posted: June 9, 2022
June 9, 2022, is International NASH Day (IND). IND is an initiative started by the Global Liver Institute to raise awareness of the growing worldwide epidemic of non-alcoholic fatty liver disease (NAFLD) and its more advanced form, non-alcoholic steatohepatitis (NASH). There are currently no approved drugs to treat NAFLD or NASH, and following a lifestyle that includes a healthy diet and regular e...Read More
News from the front lines at SOT 2022: Checkpoint Inhibitor Liver Toxicity
Posted: June 7, 2022
It’s Not Just Support. It’s Solutions. Spotlight on Liver Toxicity: Immune-mediated Liver Injury Caused by Checkpoint Inhibitors (ILICI) One thing that jumped out at the Society of Toxicology (SOT) meeting this past March was a new phase of liver toxicology research focused on therapies that have a direct effect on immune function, specifically, hepatotoxicity related to the use of...Read More
Measure True Beta Cell Dysfunction with TECO Intact Proinsulin
Posted: June 6, 2022
It’s Not Just Support. It’s Solutions. When it comes to measuring pancreatic Beta cell function, go with the Pro! TECO® Intact Proinsulin ELISA Save time and guess work by selectively measuring only intact proinsulin. Proinsulin is synthesized in pancreatic β-cells and secreted as insulin. Insulin resistance (IR) or hyperglycemia causes increased secretion and finally secretion di...Read More
T-TAS®01 - The Leading Edge in Platelet Thrombus Formation Assessment
Posted: June 1, 2022
It’s Not Just Support. It’s Solutions. Innovative Total Platelet Function Analysis using Whole Blood Global evaluation of overall hemostatic ability using physiologic, flow conditions Exclusively from DiaPharma. Advantages of T-TAS® 01 PL Assay Ease of Interpretation A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determinat...Read More
Respiratory Research Solutions from DiaPharma
Posted: May 16, 2022
It’s Not Just Support. It’s Solutions. DiaPharma is Your Exclusive Source for ProAxsis products Reach out to DiaPharma’s Olivia Stricker, who will be at American Thoracic Society (ATS) 2022 in San Francisco, May 13 – 16. Elevate your clinical research data by measuring active proteases Targets: Drug development evaluating new protease inhibitors or anti-inflam...Read More
Comprehensive Solutions for Anticoagulation Research
Posted: May 9, 2022
It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research Whether you’re researching vitamin K antagonists, thrombin inhibitors, FXa inhibitors, or contact pathway inhibitors, you need reliable, relevant tests. DiaPharma can help you select the right assays. Thrombin Generation Testing Manual or automated options for studyi...Read More
Clot Club #31
Posted: May 4, 2022
IMMUNE-MEDIATED LIVER INJURY CAUSED BY CHECKPOINT INHIBITORS (ILICI) ...Read More
What's New at DiaPharma?
Posted: April 28, 2022
It’s Not Just Support. It’s Solutions. Meet Ryan McCaw Midwest Territory Manager Ryan joined DiaPharma in January of 2022. He obtained his BS in Medicine from the University of Iowa where he also completed the Medical Technology program. He was certified as a Medical Technologist with the ASCP and started his career in medical research and had various roles in the clinical lab, both ...Read More
World Hemophilia Day
Posted: April 17, 2022
Did you know that the majority of people living with inherited bleeding disorders around the world still do not have access to diagnosis, treatment and care? DiaPharma supports World Hemophilia Day, to raise awareness and increase sustainable and equitable access to care. #WHD2022 #DiaPharma #WorldHemophiliaDay #Hemophilia #AccessForAll #LightItUpRed ML-00-00914Rev01 ...Read More
Emerging Biomarkers in Alcoholic Liver Disease
Posted: April 14, 2022
It’s Not Just Support. It’s Solutions. Non-Invasive Biomarkers for Alcoholic Liver Disease Studies Biomarkers of cell death and regeneration, inflammation, and immune response become useful tools as new potential Alcoholic Liver Disease (ALD) and Alcoholic Hepatitis (AH) treatment options are investigated. Serum biomarkers can provide valuable insights into: Disease severity and pro...Read More
Thrombin Generation Assay for Cancer Associated Thrombosis Research
Posted: April 12, 2022
It’s Not Just Support. It’s Solutions. Technothrombin® and Ceveron® TGA Thrombin Generation Testing for Cancer-Associated Thrombosis Research Thrombosis is a common complication for individuals with cancer. Risk varies by malignancy type, treatment approaches, and individual risk factors. Thrombin generation assays (TGA) provide a global context of thrombosis. When you want to meas...Read More